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INTRODUCTION
As the average life expectancy has increased, so has the number 
of patients who undergo spinal surgery for degenerative diseas-
es and have lower urinary tract symptoms. In elderly patients, 
physiological changes, such as the replacement of muscle fibers 
with collagen, lead to a reduction in contractility, and changes 
in the nerve supply from cholinergic to nonnoradrenergic and 
noncholinergic fibers lead to changes in sensation [1]. Spinal 
surgery is related to lower urinary tract dysfunction in 38%–
60% of patients [2,3]. Therefore, standard guidelines for the 
management of urinary retention are required for patients un-
dergoing spinal surgery.
 Postoperative urinary retention (POUR), defined as im-
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Purpose: Postoperative urinary retention (POUR) is a common complication after spinal surgery. However, no clear defini-
tion of POUR currently exists, and no studies have evaluated the management of POUR. We aimed to investigate the prog-
nostic factors for eventual POUR-free status in spinal surgery patients.
Methods: The records of patients who received a urologic consultation for POUR from January 2015 to December 2016 were 
reviewed. POUR-free status was defined as a voiding volume (VV) >100 mL and a VV ratio >50%. Patients with an indwell-
ing Foley catheter and those with any postoperative complications were excluded. The patients were divided into 2 groups ac-
cording to the primary management method (Foley catheterization [FC] or intermittent catheterization [IC]).
Results: In total, 205 patients (median age, 70.6 years) were evaluated. Significant prognostic factors for eventual POUR-free 
status were intraoperative FC, previous spinal surgery, operative level (L3–5), lumbar fusion, and total volume (TV) at the 
time of POUR. Bladder training and medication did not reduce the time to POUR-free status. In patients who underwent FC, 
the duration of indwelling FC was a significant prognostic factor for POUR-free status. In a subanalysis, the TV (≥500 mL) 
and VV ratio at the time of POUR were significant prognostic factors for POUR-free status after primary management. 
Among the patients who achieved a POUR-free status, 8 (6.4%) experienced recurrent POUR. The VV ratio (<62.0%) was 
the only predictor of recurrent POUR. 
Conclusions: The criterion of POUR-free status is useful after spinal surgery. IC and FC were similar in their efficacy for the 
management of these patients.
Keywords: Postoperative Period; Spinal Surgery; Urinary Catheterization; Urinary Retention
•  Research Ethics: This study was approved by the Institutional Review Board of Yonsei University College of Medicine (approval number: 2017-
0778-001). Owing to the retrospective nature of the study, written informed consent was waived. 
•  Conflict of Interest: No potential conflict of interest relevant to this article was reported.
Risk and Management of Postoperative Urinary Retention 
Following Spinal Surgery 
Kwang Suk Lee, Kyo Chul Koo, Byung Ha Chung 
Department of Urology, Yonsei University College of Medicine, Seoul, Korea
Int Neurourol J 2017;21:320-328
1 / 1CROSSMARK_logo_3_Test
2017-03-16https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg
www.einj.org    321
 Lee, et al.  •  Postoperative Urinary Retention Following Spinal Surgery INJ
Int Neurourol J 2017;21:320-328
paired voiding after surgery, increases the duration of the hos-
pital stay and causes pain [4]. The inadequate treatment of 
POUR can result in overdistention injury of the bladder, blad-
der detrusor muscle hypertrophy, and overactive voiding symp-
toms [5,6]. Among the conservative treatment options for 
POUR, Foley catheterization (FC) and intermittent catheteriza-
tion (IC) are generally considered safe for short-term use in 
neurologic patients [7]. However, the tolerability of FC and IC 
varies among patients. Additionally, the indications and efficacy 
of each treatment and the time to removal for FC are not clear. 
There are few published data on pharmacologic therapy for uri-
nary retention, as most studies have focused on prophylactic 
agents for POUR [8-10].
 Although several studies have investigated the risk factors of 
POUR after lumbar spinal surgery, to the best of our knowl-
edge, no study has explored the management of POUR in clini-
cal practice [11,12]. We suggest that a voiding care protocol 
should be developed for the management of patients after spi-
nal surgery. The aims of the present study were to investigate 
the prognostic factors of POUR-free status in patients with 
POUR after spinal surgery and to evaluate the efficacy of blad-
der training and pharmacologic therapy for treating POUR.
MATERIALS AND METHODS
Approval was obtained from the Institutional Review Board of 
Yonsei University College of Medicine (approval number: 2017-
0778-001) for collecting data on all patients treated with lumbar 
spinal surgery at our institution. The clinical variables relevant 
to the study included age, sex, body mass index, intraoperative 
FC, voiding volume (VV), residual volume (RV), voiding diary 
information, medication use (alpha-blockers), and treatment 
strategy.
Patients
The records of patients who received consultations at our urol-
ogy department for POUR after lumbar spinal surgery from 
January 2015 to December 2016 were reviewed. Patients with 
an indwelling Foley catheter to relieve the symptom of urinary 
retention before spinal surgery, those taking medication for the 
relief of voiding symptoms before surgery, and those with uri-
nary retention that developed as part of cauda equina syn-
drome in relation to a complication, such as an epidural ab-
scess, epidural hematoma, or multiple bone fracture after trau-
ma, were excluded.
Management Protocol of POUR
The consultation protocol in the urology department for all pa-
tients suspected of having POUR included the following evalu-
ations: urinalysis, urine culture, uroflowmetry, and a residual 
urine check by IC or a bladder scan (BVI-3000 BladderScan, 
Verathon Inc., Bothell, WA, USA). POUR was defined as a 
postvoid residual urine volume (PVR) >300 mL or incomplete 
bladder emptying [13]. FC was recommended for patients with 
a PVR >700 mL. The time to Foley catheter removal (days) was 
calculated as the PVR divided by 100 (for example, if the PVR 
was 700 mL, the time to Foley removal was 7 days). Pharmaco-
logic therapy was administered to treat POUR, based on the 
preferences of the patients’ attending physicians, when POUR 
developed. Although bladder training is not recommended at 
our urology department, it was performed based upon the rec-
ommendation of the patients’ attending physicians. Bladder 
training was performed by clamping prior to removing the uri-
nary catheters. The clamp was released upon the desire to void 
or after clamping for 4–6 hours without the desire to void.
Follow-up and Outcomes
POUR-free status was defined as a VV>100 mL and VV ratio 
>50%. Treatment failure was defined as (1) a change to another 
treatment according to the preferences of the physician and pa-
tient and (2) recurrent POUR after treatment with FC. The total 
volume (TV) was defined as the sum of VV. The VV ratio was 
calculated as VV divided by TV. The cutoff values of TV for pre-
dicting POUR-free status and the RV and VV ratio most suitable 
for the prediction of recurrent POUR were assessed based on the 
area under the receiver operating characteristic curve. The pa-
tients treated for POUR after surgery were divided into 2 groups 
according to the primary management method (FC vs. IC).
Statistical Analysis
Continuous variables are expressed as median (interquartile 
range). Categorical variables are reported as the number of oc-
currences and frequency. The Student t-test and Pearson chi-
square test were used to statistically compare continuous and 
categorical variables, respectively. Cox univariate and multivari-
ate analyses were performed to assess the prognostic factors of 
POUR in all spinal surgery patients. Simple and multiple logis-
tic regressions with a forward stepwise procedure were used. 
All statistical comparisons were conducted with IBM SPSS Sta-
tistics ver. 23.0 (IBM Co., Armonk, NY, USA). P-values <0.05 
were considered to indicate statistical significance.
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RESULTS
Demographic Characteristics of Patients With POUR After 
Lumbar Spinal Surgery
Table 1 shows the baseline characteristics of patients who un-
derwent a urologic consultation for POUR after lumbar spinal 
surgery. A total of 205 patients (median age, 70.6 years; median 
operative time, 3.6 hours) were evaluated, of whom 137 (66.8%) 
were operated on at the L3–5 levels. The proportions of patients 
with a history of spinal surgery, compression fracture, surgery 
at multiple levels, and lumbar fusion were 14.1%, 5.9%, 48.3%, 
and 50.7%, respectively. Medication was given to 169 patients 
(82.4%) after POUR. Intraoperative FC was performed in 132 
patients (85.7%), and the catheter was removed on postopera-
tive day 2. In patients with POUR, IC (n=135, 65.9%) or FC 
(n=70, 34.1%) was used as the primary management method. 
The FC group was younger, had a higher proportion of dura 
tearing, a longer operative time, a higher TV, and a longer dura-
tion of primary management and time to POUR-free status 
than the IC group. The failure rate of primary management 
over a median of 3 days was 39.0% (80 of 205). Among the pa-
tients who failed to achieve POUR-free status after primary 
management, 62 (77.5%) achieved POUR-free status after a 
median follow-up of 7.5 days (Fig. 1).
Predictors of Eventual POUR-Free Status
After a median of 8 days for the overall treatment, the VV ratio 
among the patients who achieved POUR-free status was 72.5%. 
Table 1. Baseline characteristics of patients with urinary retention after spinal surgery 
Variable Total (n=205) Foley catheterization group (n=70)
Intermittent catheterization 
group (n=135) P-value
Age (yr) 70.6 (62.9–74.2) 66.5 (62.1–72.8) 72.2 (64.3–75.2) 0.001
Body mass index (kg/m2) 24.3 (21.9–25.9) 23.9 (22.2–25.8) 24.4 (21.5–26.5) 0.871
Male sex 92 (44.9) 36 (51.4) 56 (41.5) 0.176
History of spinal surgery 29 (14.1) 8 (11.4) 21 (15.6) 0.405
Operative level (L3–5) 137 (66.8) 44 (62.9) 93 (68.9) 0.968
Compression fracture 12 (5.9) 6 (8.6) 6 (4.4) 0.281
Stenosis 112 (54.6) 42 (60.0) 70 (51.9) 0.269
Multiple level 99 (48.3) 36 (51.4) 63 (46.7) 0.521
Lumbar fusion 104 (50.7) 38 (54.3) 66 (48.9) 0.466
Dura tearing 32 (15.6) 20 (28.6) 12 (8.9) <0.001
Operative time (hr) 3.6 (2.4–4.8) 3.8 (2.6–5.5) 3.5 (2.2–4.3) <0.001
Intraoperative FC 180 (87.8) 58 (82.9) 122 (90.4) 0.152
Time to intraoperative Foley removal (day) 2 (2–4) 2 (2–4) 2 (2–4) 0.632
TV at POUR (mL) 550 (450–750) 750 (550–900) 500 (400–700) <0.001
VV ratio at POUR (%) 0 (0–0) 0 (0–9) 0 (0–30) <0.001
Medication after POUR 169 (82.4) 58 (82.9) 111 (82.2) 0.91
Duration of primary management (day) 3 (2–5) 5 (4–7) 2 (1–4) <0.001
Failure of primary management 80 (39.0) 26 (37.1) 54 (40.0) 0.692
Recurrent POUR after primary management 8/125 (6.4) 3/44 (6.8) 5/81 (6.2) 0.229
Overall POUR-free status 180 (87.8) 66 (94.3) 114 (84.4) 0.042
Duration of overall treatment (day) 8 (5–11) 8 (6–17) 7 (5–11) 0.003
VV at POUR-free status (mL) 300 (200–380) 300 (225–387) 300 (200–350) 0.592
RV at POUR-free status (mL) 100 (41–200) 79 (20–117) 100.0 (50–200) 0.262
VV ratio POUR-free status (%) 72.5 (56.7–88.3) 77.8 (64.9–93.6) 65.9 (52.6–83.3) 0.009
Values are presented as median (interquartile range) or number (%).      
FC, Foley catheterization; TV, total volume; POUR, postoperative urinary retention; VV, voiding volume; RV, residual volume.  
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In a Cox multivariate analysis of the prognostic factors of even-
tual POUR-free status, intraoperative FC (hazard ratio [HR], 
0.24; 95% confidence interval [CI], 0.144–0.403; P<0.001), pre-
vious spinal surgery (HR, 0.49; 95% CI, 0.302–0.785; P=0.003), 
operative level (L3–5) (HR, 2.00; 95% CI, 1.437–2.778; P<0.001), 
lumbar fusion (HR, 0.68; 95% CI, 0.490–0.933; P=0.017), and 
TV at POUR (≥500 mL) (HR, 0.48; 95% CI, 0.346–0.661; P< 
0.001) were significant prognostic factors (Table 2). The prima-
ry management method for POUR (FC vs. IC) and medication 
use were not significant prognostic factors of eventual POUR-
free status.
 In patients who underwent IC, intraoperative FC (HR, 0.50; 
95% CI, 0.333–0.754; P=0.001), operative level (L3–5) (HR, 1.89; 
95% CI, 1.224–2.903; P=.004), lumbar fusion (HR, 0.61; 95% 
CI, 0.403–0.914; P=0.017), and TV at POUR (≥500 mL) (HR, 
0.28; 95% CI, 0.136–0.554; P<0.001) were significant prognostic 
factors of eventual POUR-free status. In patients who underwent 
FC, intraoperative FC (HR, 0.21; 95% CI, 0.088–0.0512; P = 
0.001), surgery at multiple levels (HR, 0.24; 95% CI, 0.126–0.467; 
P <.001), medication use (HR, 0.40; 95% CI, 0.188–0.853; 
P=0.018), and duration of indwelling FC (≥4 days) (HR, 2.85; 
95% CI, 1.631–4.965; P<0.001) were significant prognostic fac-
tors of eventual POUR-free status; bladder training was also a 
prognostic factor of eventual POUR-free status.
Predictors of POUR-Free Status After Primary Management
In a Cox multivariate analysis of the prognostic factors of 
POUR-free status after primary management, a compression 
fracture (HR, 0.33; 95% CI, 0.150–0.721; P=0.006), surgery at 
multiple levels (HR, 0.56; 95% CI, 0.371–0.838; P=0.005), TV at 
POUR (≥500 mL) (HR, 0.54; 95% CI, 0.360–0.802; P=0.002), 
VV ratio at POUR (HR, 1.03; 95% CI, 1.024–1.042; P<0.001), 
and FC (HR, 0.39; 95% CI, 0.250–0.606; P<0.001) were signifi-
cant prognostic factors of POUR-free status (Table 3).
 Subanalyses for the predictors of POUR-free status were per-
formed according to the primary management method. In 
multivariate analysis, the operative level (L3–5) (HR, 3.46; 95% 
CI, 1.916–6.265; P<0.001), lumbar fusion (HR, 0.42; 95% CI, 
0.262–0.677; P <0.001), and TV at POUR ( ≥500 mL) (HR, 
0.27; 95% CI, 0.162–0.454; P<0.001) were significant prognos-
tic factors of POUR-free status in patients who underwent IC. 
Surgery at multiple levels (HR, 0.16; 95% CI, 0.076–0.345; 
P<0.001) and the duration of indwelling FC (≥4 days) (HR, 
3.56; 95% CI, 1.596–7.962; P=0.002) were significant prognos-
tic factors of POUR-free status in patients who underwent FC.
Predictors of Recurrent POUR Among Patients With POUR-
Free Status
Among the 125 patients with POUR-free status after primary 
Fig. 1. Flowchart of the study selection process. 
213 Patients with postoperative urinary retention (POUR) after lumbar spinal surgery
205 Primary management (Foley catheterization [n=70] and intermittent catheterization [n=135])
180 Eventual POUR-free
125 POUR-free after primary management
80 POUR-failure after primary management8 Recurrent POUR
117 Persistent POUR-free
25 Eventual POUR-failure
88 Additional treatment 
8 Excluded
- Foley catheter indwelling before spinal surgery 
- Taking medication for relief of voiding symptoms before 
 spinal surgery 
- Cauda equina syndrome in relation to a surgical complication
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Table 2. Prognostic factors for overall POUR-free status in patients with urinary retention after spinal surgery
Variable
Univariate analysis Multivariate analysis
HR 95% CI P-value HR 95% CI P-value
Age 1.00 0.981–1.015 0.811 - - -
Sex, male vs. female 1.42 1.054–0.898 0.021 1.26 0.929–1.704 0.137
Intraoperative FC 0.19 0.119–0.314 <0.001 0.24 0.144–0.403 <0.001
History of spinal surgery 0.55 0.346–0.882 0.013 0.49 0.302–0.785 0.003
Operative level (L3–5) 2.27 1.640–3.146 <0.001 2.00 1.437–2.778 <0.001
Compression fracture 0.45 0.238–0.862 0.016 0.69 0.350–1.373 0.294
Stenosis 1.09 0.805–1.461 0.593 - - -
Multiple level 0.53 0.387–0.719 <0.001 0.85 0.580–1.240 0.396
Fixation 0.61 0.453–0.823 0.001 0.68 0.490–0.933 0.017
Dura tearing 0.83 0.555–1.254 0.382 - - -
Operative time (hr) 0.97 0.892–1.045 0.38 - - -
TV at POUR (≥500 mL) 0.57 0.419–0.777 <0.001 0.48 0.346–0.661 <0.001
VV ratio at POUR 1.01 0.995–10.21 0.229 - - -
Use of medication 0.90 0.606–1.329 0.589 - - -
Methods of management, FC vs. IC 0.84 0.619–1.142 0.268 - - -
POUR, postoperative urinary retention; HR, hazard ratio; CI, confidence interval; FC, Foley catheterization; TV, total volume; VV, voiding volume; 
IC, intermittent catheterization.      
Table 3. Prognostic factors for POUR-free status in patients who underwent primary management methods for urinary retention af-
ter spinal surgery
Variable
Univariate analysis Multivariate analysis
HR 95% CI P-value HR 95% CI P-value
Age 1.00 0.978–1.019 0.880 - - -
Sex, male vs. female 1.52 1.055–2.200 0.025 1.12 0.710–1.761 0.629
Intraoperative FC 0.74 0.440–1.238 0.250 - - -
History of spinal surgery 0.77 0.432–1.370 0.373 - - -
Operative level (L3–5) 2.47 1.595–3.820 <0.001 1.61 0.971–2.661 0.065
Compression fracture 0.32 0.140–0.744 0.008 0.33 0.150–0.721 0.006
Stenosis 1.22 0.851–1.759 0.275 - - -
Multiple level 0.59 0.409–0.851 0.005 0.56 0.371–0.838 0.005
Lumbar fusion 0.78 0.541–1.112 0.167 - - -
Dura tearing 0.54 0.320–0.893 0.017 1.07 0.578–1.962 0.839
Operative time (hr) 0.95 0.876–1.033 0.234 - - -
TV at POUR (≥500 mL) 1.00 0.998–0.999 0.001 0.54 0.360–0.802 0.002
VV ratio at POUR 1.02 1.007–1.035 0.003 1.03 1.024–1.042 <0.001
Use of medication 0.79 0.495–1.251 0.310 - - -
Methods of management, FC vs. IC 0.36 0.242–0.544 <0.001 0.39 0.250–0.606 <0.001
POUR, postoperative urinary retention; HR, hazard ratio; CI, confidence interval; FC, Foley catheterization; TV, total volume; VV, voiding volume; 
IC, intermittent catheterization.      
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management, 8 (6.4%) experienced recurrent POUR. Among 
the patients who experienced recurrent POUR, only 1 patient 
achieved eventual POUR-free status after additional treatment 
during the observation period. In patients with recurrent 
POUR, the RV, TV, and VV ratio after primary management 
were found to be prognostic factors in the univariate analysis. 
In the multivariate analysis, the VV ratio (<62.0%) (odds ratio 
[OR], 6.31; 95% CI, 1.433–27.810; P=0.015) was the only pre-
dictor of recurrent POUR. The primary management method 
for POUR (FC vs. IC) and medication use were not significant 
risk factors for recurrent POUR (Table 4).
 Of the patients who underwent FC as the primary manage-
ment method, 20 (28.5%) underwent a retrograde voiding trial. 
However, retrograde and spontaneous voiding trials were not a 
predictor of recurrent POUR (P=0.605).
DISCUSSION
POUR is a poorly understood, yet well-recognized, postopera-
tive complication in both men and women [13]. Although the 
reported incidence of POUR has varied among previous stud-
ies, approximately 20% of patients who receive general anesthe-
sia for lumbar surgery experience POUR [14-17]. As the elderly 
population increases, the number of patients who develop 
POUR after lumbar surgery will increase. Previous studies of 
POUR have focused on the investigation of preoperative/peri-
operative risk factors, such as age, history of benign prostatic 
hyperplasia, chronic constipation, and use of patient-controlled 
analgesia [2,14,17,18]. However, no clear definition of POUR 
currently exist, and the criteria to rule out POUR remain un-
clear [18,19]. Our findings will be used to develop a prospective 
POUR care protocol to be used in clinical practice.
 Although very strict and aggressive criteria have been advo-
cated to provide a maximally safe management protocol, this 
could lead to overtreatment in a large proportion of patients 
whose condition deteriorates immediately after spinal surgery. 
In our study, the cutoff value for the VV ratio was 62%, and this 
was the only predictor of recurrent POUR. This finding was 
consistent with the general recommendation by urologists that 
clinicians should monitor patients continuously to prevent 
overdistention until the PVR is consistently less than one-third 
of the TV [20].
 Altschul et al. [12] reported that intraoperative Foley place-
ment (OR, 3.42; P=0.004) was a predictor of the development 
of POUR in a cohort of 397 patients who underwent elective 
spine surgery. Our results are similar to the findings of this pre-
vious report. However, some controversy exists regarding the 
time to intraoperative Foley catheter removal as a prognostic 
factor. Although a previous study reported no significant differ-
ence in the development of POUR between patients whose 
Table 4. Prognostic factors for recurrent POUR among patients with POUR-free status in those who underwent primary manage-
ment methods for urinary retention after spinal surgery
Variable
Univariate analysis Multivariate analysis
OR 95% CI P-value OR 95% CI P-value
Age 1.06 0.973–1.162 0.173 - -
Sex, male vs. female 0.39 0.075–2.007 0.259 - - -
Operative level (L3–5) 1.03 0.198–5.404 0.968 - - -
Stenosis 2.32 0.449–11.968 0.315 - - -
Multiple level 0.43 0.084–2.227 0.315 - - -
Lumbar fusion 0.89 0.170–4.616 0.885 - - -
Operative time (hr) 0.73 0.462–1.143 0.167 - - -
RV after primary management 1.13 1.008–1.019 0.001 1.01 0.994–1.031 0.179
TV after primary management 1.08 1.043–1.143 0.049 0.92 0.079–10.632 0.946
VV ratio (<62.0%) after primary management 5.50 1.136–26.633 0.034 6.31 1.433–27.810 0.015
Duration of the primary treatment 1.07 0.966–1.174 0.204 - - -
Methods of management, FC vs. IC 1.23 0.990–1.528 0.062 - - -
POUR, postoperative urinary retention; OR, odds ratio; CI, confidence interval; RV, residual volume; TV, total volume; VV, voiding volume; FC, Fol-
ey catheterization; IC, intermittent catheterization.      
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catheter was removed on day 1 or day 3 after vaginal prolapse 
surgery, Chong et al. found that the incidence of POUR was 
significantly higher in the 1-day catheter group than in the 
4-day catheter group [18, 21]. Our cohort underwent lumbar 
spinal surgery, and most patients routinely underwent intraop-
erative Foley removal on postoperative day 2. Therefore, this 
study identified no cutoff value of the time to intraoperative 
Foley removal. Regardless, no studies have evaluated the intra-
operative holding period of FC in patients with POUR after 
spinal surgery. Our findings showed that maintaining catheter 
placement for ≥4 days had a positive prognostic effect on pa-
tients’ recovery from POUR.
 In the present study, patients who underwent FC had a worse 
status than patients who underwent IC in terms of dura tearing, 
operative time, TV at POUR, and VV ratio at POUR, but no 
significant differences in the prognosis of eventual POUR-free 
status were found between those who underwent FC and IC. 
Some of the factors that affect the decision to perform FC are 
the fact that it is a bothersome and somewhat painful proce-
dure, the possibility of long-term use, and incidence of imme-
diate POUR after short-term indwelling catheterization. In a 
previous study, FC was performed when patients with POUR 
required more than 2 consecutive rounds of IC [12]. In this 
study, we identified useful parameters in clinical practice, such 
as a history of spinal surgery, operative level (L3–5), and lumbar 
fusion, as predictors of eventual POUR-free status. The distal 
end of the spinal cord becomes conical at the level of T12, and 
it is thus called the conus medullaris. This structure reaches the 
level of the L2 body and ends with the cauda equina, which is 
composed of the last nervous roots (including the ones from/to 
the bladder) and the filum terminale [22]. Although degenera-
tive diseases of the spine, such as the lumbar disc, involve L4/L5 
and L5/S1, this study divided patients according to whether the 
operative level was L1–2 or L3–5. We then identified the opera-
tive level (L3–5) as a positive prognostic factor for eventual 
POUR-free status. Although there was no difference in thera-
peutic efficacy between FC and IC, these criteria are useful for 
establishing a management plan in clinical settings.
 The efficacy of bladder training and retrograde and sponta-
neous voiding trials remains controversial. Although bladder 
training seems to help patients restore voluntary urinary void-
ing, this study found that it had no significant effect on increas-
ing the chance of a successful voiding trial in patients with 
POUR after spinal surgery. Our results are consistent with those 
of previous studies [23,24]. Geller et al. [25] assessed the diag-
nostic accuracy of retrograde and spontaneous voiding trials in 
a randomized controlled trial in 100 patients with POUR. They 
reported that retrograde voiding trials, in which the bladder is 
filled in a retrograde manner through a catheter with 300 mL of 
sterile saline or until the patient desires voiding at maximum 
capacity, were more accurate for evaluating postoperative void-
ing dysfunction than spontaneous voiding trials. However, 
whether a patient underwent a retrograde or spontaneous void-
ing trial was not a significant factor in the prediction of recur-
rent POUR in our study.
 Several drugs are commonly used for the management of 
urinary retention, including cholinergic agents, prostaglandins, 
alpha-blockers, and sedatives. In a recent study investigating 
the prophylactic effects of tamsulosin and alfuzosin, the use of 
alpha-blockers was associated with the prevention of POUR in 
men after spinal anesthesia in urologic surgery procedures [26]. 
However, the efficacy of pharmacologic therapy on POUR 
treatment remains unclear. In Korea, alpha-blockers are reim-
bursed for patients with POUR. Some attending physicians of 
patients with POUR considered the use of alpha-blockers to 
achieve faster bladder function recovery, to shorten the dura-
tion of hospitalization, or to reduce healthcare costs, despite the 
absence of high-level evidence of the efficacy of pharmacologic 
therapy on POUR management. This retrospective study found 
that medication use was not associated with eventual POUR-
free status in patients with POUR. However, further research 
into the effects of pharmacologic therapy on POUR based on a 
well-designed protocol is warranted. 
 The present study has several limitations. The indications for 
a urologic consultation for POUR lacked standardization, and 
selection bias may have been present. Although no differences 
in the eventual POUR-free rate were found between the FC and 
IC groups, FC was more frequently recommended for patients 
with more severe complications such as dura tearing, a longer 
operative time, a higher TV at POUR, and a higher VV ratio at 
POUR. Additionally, we were unaware of the number of pa-
tients who were missed due to not having a consultation with 
the urology department. Nevertheless, we believe that this effect 
is inherent to any retrospective study, and future studies are re-
quired for greater generalizability. Another limitation is the 
possibility that the inclusion of patients treated by multiple spi-
nal surgeons at a single institution could have accounted for the 
heterogeneity in the results. Potential factors such as variability 
in surgical management and postoperative care among sur-
geons might limit the generalizability of our results. Finally, this 
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study did not evaluate risk factors such as time to ambulation, 
intraoperative/perioperative anesthetic use, and past medical 
history (diabetes mellitus, baseline bladder function). These 
factors may have affected any subsequent occurrence of POUR, 
possibly influencing the eventual POUR-free rate. Only some 
patients underwent a bladder function test, such as a urody-
namic study, after the incidence of POUR. However, we believe 
that our patients may reflect those in real-world clinical practice 
in terms of primary management after spinal surgery. 
 POUR-free status was defined as a VV >100 mL and a VV 
ratio >50%, and this was the outcome evaluated in our efficacy 
analysis. There was no difference in the efficacy of POUR man-
agement between IC and FC. In patients with POUR who un-
derwent FC, the duration of FC ( ≥4 days) was a prognostic 
factor of POUR-free status. Bladder training and the use of al-
pha-blockers did not reduce the time to POUR-free status.
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